🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

68+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 68 recruiting trials for “chronic-thromboembolic-pulmonary-hypertension

Phase 1RecruitingNCT06872112

A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension

👨‍⚕️ Roham Zamanian, MD, Stanford University📍 1 site📅 Started Jan 2026View details ↗
RecruitingNCT07272798

Cardiac Self-Efficacy in Patients With Chronic Thromboembolic Pulmonary Hypertension

👨‍⚕️ Mohammad B Izzat, FRCS(CTh), Damascus University School of Medicine📍 1 site📅 Started Nov 2025View details ↗
Phase 2RecruitingNCT06351345

129 Xenon Imaging in Patients Treated With Sotatercept

👨‍⚕️ Sudarshan Rajagopal, MD, PhD, Duke University📍 1 site📅 Started Oct 2025View details ↗
Phase 4RecruitingNCT07140484

Sotatercept in Pulmonary Arterial Hypertension

👨‍⚕️ Jason Weatherald, MD, University of Alberta📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07175038

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

🏥 AllRock Bio, Inc.📍 13 sites📅 Started Oct 2025View details ↗
RecruitingNCT07299227

Impact of BPA in CTEPH on Cardiac and Pulmonary Physiology Assessed by CMR-derived 4D Flow Haemodynamics

🏥 Kerckhoff Klinik📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT07217522

Rutgers University Study of the Genetics of Pulmonary Hypertension

👨‍⚕️ Tara Matise, Ph.D., Rutgers, The State University of New Jersey📍 1 site📅 Started Aug 2025View details ↗
RecruitingNCT07013149

The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension

🏥 University of Sao Paulo General Hospital📍 1 site📅 Started Aug 2025View details ↗
RecruitingNCT06998329

PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch

🏥 University of Sao Paulo General Hospital📍 1 site📅 Started Jul 2025View details ↗
Phase 2Enrolling by InvitationNCT06992440

Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

👨‍⚕️ Gustavo Heresi, MD, The Cleveland Clinic📍 3 sites📅 Started Jun 2025View details ↗
NARecruitingNCT06968962

Comparison of Sequential to Initial Combination Therapy in PAH

🏥 Second Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started May 2025View details ↗
RecruitingNCT07254078

Registry of Patients With chrOnic thromboemboLic Pulmonary hypErTension

🏥 Irina E. Chazova📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT07457762

AIRDROP: Can we Improve Adherence to Inhaled Treatment for Pulmonary Arterial Hypertension?

🏥 University of Sao Paulo General Hospital📍 1 site📅 Started May 2025View details ↗
Phase 3RecruitingNCT06941441

PAH Exercise Study

👨‍⚕️ Mary Beth Brown, PT, PhD, University of Washington📍 1 site📅 Started Apr 2025View details ↗
Phase 3RecruitingNCT06922240

Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)

🏥 Suqiao Yang📍 3 sites📅 Started Mar 2025View details ↗
NARecruitingNCT06804122

Exercise-based Rehabilitation in Patients With Pulmonary Arterial Hypertension

👨‍⚕️ Jussi A Hernesniemi, MD PhD, Tampere Heart Hospital📍 1 site📅 Started Jan 2025View details ↗
Phase 3RecruitingNCT05140525

Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH

👨‍⚕️ Sudarshan Rajagopal, MD, PhD, Duke Health System📍 1 site📅 Started Jan 2025View details ↗
RecruitingNCT06081881

Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism

👨‍⚕️ Ester A Faried, Resident, Assiut University📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06549452

Mobile Health Intervention to Improve Exercise in Pediatric PH

👨‍⚕️ Eric Austin, MD, Vanderbilt University Medical Center📍 1 site📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06649110

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

🏥 Novartis Pharmaceuticals📍 29 sites📅 Started Oct 2024View details ↗
Page 1 of 4Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →